BIOSIMILARS: Era of Biologic Medicine
Biosimilars are significant as they have an opportunity to provide competition in the market and develop patient access to critical medicines, much like the dawn of generic medications more than 35 years ago. With the emerging need and evolution of the Biosimilars, we have come up with an interactive Whitepaper through which you can assess the important areas and complete history of Biosimilars.
- Approval pathways of the Biosimilars in US FDA and Europe
- Various acts related to Biosimilars
- Biosimilars Top Leaders & Competitive Landscape